Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13944569
[patent_doc_number] => 10208040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Fused imidazo-piperidine JAK inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/915434
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24542
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915434 | Fused imidazo-piperidine JAK inhibitors | Mar 7, 2018 | Issued |
Array
(
[id] => 14596711
[patent_doc_number] => 10351537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Processes for the preparation of lesinurad and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 15/914165
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14172
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914165 | Processes for the preparation of lesinurad and intermediates thereof | Mar 6, 2018 | Issued |
Array
(
[id] => 15308949
[patent_doc_number] => 10519165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Processes for preparing ACC inhibitors and solid forms thereof
[patent_app_type] => utility
[patent_app_number] => 15/910744
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 39541
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910744 | Processes for preparing ACC inhibitors and solid forms thereof | Mar 1, 2018 | Issued |
Array
(
[id] => 16842869
[patent_doc_number] => 11014943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Azetidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/489282
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16380
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489282
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489282 | Azetidine derivative | Feb 27, 2018 | Issued |
Array
(
[id] => 16770812
[patent_doc_number] => 10981900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Spiro compound and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/489476
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24638
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489476 | Spiro compound and use thereof | Feb 27, 2018 | Issued |
Array
(
[id] => 16877921
[patent_doc_number] => 11028054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/488151
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23042
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488151 | 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors | Feb 22, 2018 | Issued |
Array
(
[id] => 15435243
[patent_doc_number] => 20200031805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => ARYL HYDROCARBON RECEPTOR (AHR) MODULATOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/483981
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483981 | ARYL HYDROCARBON RECEPTOR (AHR) MODULATOR COMPOUNDS | Feb 20, 2018 | Abandoned |
Array
(
[id] => 14913509
[patent_doc_number] => 10428060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => PI-kinase inhibitors with anti-infective activity
[patent_app_type] => utility
[patent_app_number] => 15/892965
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27966
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892965 | PI-kinase inhibitors with anti-infective activity | Feb 8, 2018 | Issued |
Array
(
[id] => 13413069
[patent_doc_number] => 20180258077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => 5-SULFANYLHISTIDINES AND THEIR DISULFIDES AND METHOD OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/891433
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891433
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891433 | 5-SULFANYLHISTIDINES AND THEIR DISULFIDES AND METHOD OF PREPARATION THEREOF | Feb 7, 2018 | Abandoned |
Array
(
[id] => 15496157
[patent_doc_number] => 20200048267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => OGA INHIBITOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/482327
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482327 | OGA INHIBITOR COMPOUNDS | Feb 5, 2018 | Abandoned |
Array
(
[id] => 14055381
[patent_doc_number] => 10231967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Compounds and their use as BACE inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/884752
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 65267
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15884752
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/884752 | Compounds and their use as BACE inhibitors | Jan 30, 2018 | Issued |
Array
(
[id] => 15491557
[patent_doc_number] => 20200045967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => NOVEL TRIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/484076
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484076 | NOVEL TRIAZOLE DERIVATIVES | Jan 28, 2018 | Abandoned |
Array
(
[id] => 17665278
[patent_doc_number] => 11358959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Benzothiophene and benzothiazole compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/480861
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23983
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 427
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480861 | Benzothiophene and benzothiazole compounds and methods of use thereof | Jan 24, 2018 | Issued |
Array
(
[id] => 12769753
[patent_doc_number] => 20180148419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 15/879792
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879792
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879792 | Benzoimidazol-1,2-yl amides as Kv7 channel activators | Jan 24, 2018 | Issued |
Array
(
[id] => 13746573
[patent_doc_number] => 10166211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-01-01
[patent_title] => Nitric oxide releasing compound, pharmaceutical composition, use and synthesis method thereof
[patent_app_type] => utility
[patent_app_number] => 15/879450
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 108
[patent_no_of_words] => 5616
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879450 | Nitric oxide releasing compound, pharmaceutical composition, use and synthesis method thereof | Jan 24, 2018 | Issued |
Array
(
[id] => 12766054
[patent_doc_number] => 20180147186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/879130
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879130
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879130 | BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME | Jan 23, 2018 | Abandoned |
Array
(
[id] => 16549688
[patent_doc_number] => 10882837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Amide compounds and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/475900
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20705
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475900 | Amide compounds and use thereof | Jan 21, 2018 | Issued |
Array
(
[id] => 15086209
[patent_doc_number] => 20190337915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => AMIDE COMPOUNDS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/477072
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 374
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477072 | Amide compounds and use thereof | Jan 21, 2018 | Issued |
Array
(
[id] => 17697051
[patent_doc_number] => 11370761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Voltage-dependent T-type calcium channel inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/479674
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17854
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479674 | Voltage-dependent T-type calcium channel inhibitor | Jan 21, 2018 | Issued |
Array
(
[id] => 16792903
[patent_doc_number] => 20210122720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PROCESS FOR THE PREPARATION OF AN ACESULFAME WITH SULPHURIC ACID PROCESSING
[patent_app_type] => utility
[patent_app_number] => 16/963145
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963145 | Process for the preparation of an acesulfame with sulphuric acid processing | Jan 17, 2018 | Issued |